Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis

Arun J. Sanyal, Vlad Ratziu, Rohit Loomba, Quentin M. Anstee, Kris V. Kowdley, Mary E. Rinella, Muhammad Y. Sheikh, James F. Trotter, W Knapple, Eric Lawitz, Manal F. Abdelmalek, Philip N. Newsome, Jérôme Boursier, Philippe Mathurin, Jean‐François Dufour, M. Michelle Berrey, Steven J. Shiff, Sangeeta Sawhney, Thomas Capozza, Rina Leyva, Stephen A. Harrison, Z.M. Younossi